ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction

被引:65
作者
Chen, Xing [1 ]
Zhou, Zhihan [2 ]
Zhao, Yan [1 ]
机构
[1] China Univ Min & Technol, Sch Informat & Control Engn, 1 Daxue Rd, Xuzhou 221116, Jiangsu, Peoples R China
[2] Zhejiang Univ, Sch Math Sci, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
association prediction; disease; ensemble learning; link prediction; microRNA; SUPPRESSES TUMOR-GROWTH; HUMAN MICRORNA; PROGNOSTIC MARKER; PROSTATE-CANCER; BREAST-CANCER; LUNG-CANCER; EXPRESSION; TARGET; PROLIFERATION; METASTASIS;
D O I
10.1080/15476286.2018.1460016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, accumulating evidences have indicated miRNAs play critical roles in the progression and development of various human complex diseases, which pointed out that identifying miRNA-disease association could enable us to understand diseases at miRNA level. Thus, revealing more and more potential miRNA-disease associations is a vital topic in biomedical domain. However, it will be extremely expensive and time-consuming if we examine all the possible miRNA-disease pairs. Therefore, more accurate and efficient methods are being highly requested to detect potential miRNA-disease associations. In this study, we developed a computational model of Ensemble Learning and Link Prediction for miRNA-Disease Association prediction (ELLPMDA) to achieve this goal. By integrating miRNA functional similarity, disease semantic similarity, miRNA-disease association and Gaussian profile kernel similarity for miRNAs and diseases, we constructed a similarity network and utilized ensemble learning to combine rank results given by three classic similarity-based algorithms. To evaluate the performance of ELLPMDA, we exploited global and local Leave-One-Out Cross Validation (LOOCV), 5-fold Cross Validation (CV) and three kinds of case studies. As a result, the AUCs of ELLPMDA is 0.9181, 0.8181 and 0.9193+/-0.0002 in global LOOCV, local LOOCV and 5-fold CV, respectively, which significantly exceed almost all the previous methods. Moreover, in three distinct kinds of case studies for Kidney Neoplasms, Lymphoma, Prostate Neoplasms, Colon Neoplasms and Esophageal Neoplasms, 88%, 92%, 86%, 98% and 98% out of the top 50 predicted miRNAs has been confirmed, respectively. Besides, ELLPMDA is based on global similarity measure and applicable to new diseases without any known related miRNAs.
引用
收藏
页码:807 / 818
页数:12
相关论文
共 84 条
[1]   miR-519 suppresses tumor growth by reducing HuR levels [J].
Abdelmohsen, Kotb ;
Kim, Mihee M. ;
Srikantan, Subramanya ;
Mercken, Evi M. ;
Brennan, Sarah E. ;
Wilson, Gerald M. ;
de Cabo, Rafael ;
Gorospe, Myriam .
CELL CYCLE, 2010, 9 (07) :1354-1359
[2]   Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures [J].
Alshalalfa, Mohammed ;
Alhajj, Reda .
BMC BIOINFORMATICS, 2013, 14
[3]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[4]  
[Anonymous], NUCL ACIDS RES
[5]  
[Anonymous], 1901, Bull. Soc. Vaudoise Sci. Nat
[6]  
[Anonymous], BIOINFORMATICS
[7]   MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[8]   miR-335 and miR-34a Promote Renal Senescence by Suppressing Mitochondrial Antioxidative Enzymes [J].
Bai, Xue-Yuan ;
Ma, Yuxiang ;
Ding, Rui ;
Fu, Bo ;
Shi, Suozhu ;
Chen, Xiang-Mei .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (07) :1252-1261
[9]  
Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6
[10]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233